The MetroWest Daily News10d
Mass. budget includes language expanding access to preventative HIV medications
The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.
Pathbreaking HIV drug’s generic version to be made in India
Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...
Bay Area Reporter2d
LGBTQ Agenda: Biden administration expands injectable PrEP coverage
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
independent.co.ug1d
‘Antiretrovirals Alone Will Not End the HIV Pandemic’
HIV Research for Prevention Conference ANALYSIS | SETHI NCUBE | The 5th HIV Research for Prevention Conference (HIVR4P 2024) ...
pharmaphorum7h
Gilead's HIV success and controversy: Expanding access amid criticism
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
ABC News25d
Why progress against HIV/AIDS has stalled among Hispanic and Latino Americans
"Where we are in the HIV epidemic is that we have better tools than ever for both treatment and for prevention ... or a missed opportunity to receive post-exposure prophylaxis, which can reduce ...
Business Line22d
Dr. Reddy’s and Hetero join hands with Gilead to broaden access to HIV drug Lenacapavir in low-income countries
“Lenacapavir marks an important milestone for Dr. Reddy’s in patient access and affordability for pre and post exposure treatment of HIV. The collaboration with Gilead will help us make this ...
Bridging the gap between science and community in HIV response
Natal, alarming gaps between scientific advancements and community behaviour persist. This article explores the critical need ...